In cancers, the M1-M2 programs are thought to rely principally on metabolism by various signaling pathways, including the phosphatidylinositol 3-kinase (PI3K)-AKT, c-Myc, HIF, AMPK, and PPAR pathways. The gene discussed is AKT1; the disease is cancer.